Furthermore, OPCs downregulated several well-established large intestinal cancer stem cell markers such as CD133, CD44 and LGR5, indicating that OPCs particularly target cancer stem cells in CRC (Fig. 2D). Here, PROM1 is linked to intestinal cancer.